New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism
Kaidireyahan Wumaier,1 Wenqian Li,1 Jiuwei Cui2 1The First Hospital of Jilin University, Jilin University, Changchun, People’s Republic of China; 2Department of Cancer Center, the First Hospital of Jilin University, Changchun, People’s Republic of ChinaCorrespondence: Jiuwei Cui, Department of Cance...
Main Authors: | Wumaier K, Li W, Cui J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-08-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/new-oral-anticoagulants-open-new-horizons-for-cancer-patients-with-ven-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Expanding the possibilities of treatment and prevention of venous thromboembolic complications in cancer patients. The role of oral anticoagulants
by: R. A. Bredikhin, et al.
Published: (2022-10-01) -
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
by: Kaidireyahan Wumaier, et al.
Published: (2021-09-01) -
Direct oral anticoagulants in cancer-associated venous thromboembolism
by: Kirill Lobastov, et al.
Published: (2020-01-01) -
The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01) -
The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
by: К. V. Lobastov, et al.
Published: (2020-05-01)